Tag: Alterity Therapeutics
United States opens clinical trial enrollment for treatment of progressive Parkinsonian...
Alterity Therapeutics launches ATH434 Phase 2 Clinical Trial in the United States for the treatment of individuals with Multiple System Atrophy